Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does the Choice of Administration Sequence of Propofol and Remifentanil Affect the ED50 and ED95 of Rocuronium for Rapid Sequence Induction of Anesthesia?

NCT02709473 is registered in ClinicalTrials.gov with Ankara University as lead sponsor.

NCT NCT02709473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02709473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does the Choice of Administration Sequence of Propofol and Remifentanil Affect the ED50 and ED95 of Rocuronium for Rapid Sequence Induction of Anesthesia?
Lead sponsor
Ankara University
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2016
Completion date
April 30, 2016
Enrollment
84 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, neuromuscular blockade